Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Blood Advances|September 17, 2021
A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemiaChristian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Haematologica|August 27, 2016
Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisTobias Herold, Stephanie Schneider, Klaus H Metzeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune InfiltrationJoshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Elife|December 20, 2016
Epithelial magnesium transport by TRPM6 is essential for prenatal development and adult survivalVladimir Chubanov, Silvia Ferioli, Annika Wisnowsky, et al.
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Hemasphere|July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product UseVeit Bücklein, Ariel Perez, Kai Rejeski, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Pageof 7